Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 330

1.

Somatostatin receptor-binding peptides suitable for tumor radiotherapy with Re-188 or Re-186. Chemistry and initial biological studies.

Cyr JE, Pearson DA, Wilson DM, Nelson CA, Guaraldi M, Azure MT, Lister-James J, Dinkelborg LM, Dean RT.

J Med Chem. 2007 Mar 22;50(6):1354-64. Epub 2007 Feb 22.

PMID:
17315859
2.

Synthesis, characterization, and labeling with 99mTc/188Re of peptide conjugates containing a dithia-bisphosphine chelating agent.

Gali H, Hoffman TJ, Sieckman GL, Owen NK, Katti KV, Volkert WA.

Bioconjug Chem. 2001 May-Jun;12(3):354-63.

PMID:
11353532
4.
5.

Noninvasive monitoring of gene transfer using a reporter receptor imaged with a high-affinity peptide radiolabeled with 99mTc or 188Re.

Zinn KR, Buchsbaum DJ, Chaudhuri TR, Mountz JM, Grizzle WE, Rogers BE.

J Nucl Med. 2000 May;41(5):887-95.

6.

Radiochemical investigations of [188Re(H2O)(CO)3-diaminopropionic acid-SSS-bombesin(7-14)NH2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies.

Smith CJ, Sieckman GL, Owen NK, Hayes DL, Mazuru DG, Volkert WA, Hoffman TJ.

Anticancer Res. 2003 Jan-Feb;23(1A):63-70.

PMID:
12680195
7.

Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide.

Maresca KP, Marquis JC, Hillier SM, Lu G, Femia FJ, Zimmerman CN, Eckelman WC, Joyal JL, Babich JW.

Bioconjug Chem. 2010 Jun 16;21(6):1032-42. doi: 10.1021/bc900517x.

PMID:
20402463
8.

Somatostatin receptor-binding peptides labeled with technetium-99m: chemistry and initial biological studies.

Pearson DA, Lister-James J, McBride WJ, Wilson DM, Martel LJ, Civitello ER, Taylor JE, Moyer BR, Dean RT.

J Med Chem. 1996 Mar 29;39(7):1361-71.

PMID:
8691466
9.

99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.

von Guggenberg E, Behe M, Behr TM, Saurer M, Seppi T, Decristoforo C.

Bioconjug Chem. 2004 Jul-Aug;15(4):864-71.

PMID:
15264875
10.

[99mTc]oxotechnetium(V) complexes amine-amide-dithiol chelates with dialkylaminoalkyl substituents as potential diagnostic probes for malignant melanoma.

Friebe M, Mahmood A, Bolzati C, Drews A, Johannsen B, Eisenhut M, Kraemer D, Davison A, Jones AG.

J Med Chem. 2001 Sep 13;44(19):3132-40.

PMID:
11543682
11.
12.

Effects of lysine-containing mercaptoacetyl-based chelators on the biodistribution of 99mTc-labeled anti-HER2 Affibody molecules.

Tran TA, Ekblad T, Orlova A, Sandström M, Feldwisch J, Wennborg A, Abrahmsén L, Tolmachev V, Eriksson Karlström A.

Bioconjug Chem. 2008 Dec;19(12):2568-76. doi: 10.1021/bc800244b.

PMID:
19035668
13.

Synthesis and in vitro evaluation of a rhenium-cyclized somatostatin derivative series.

Bigott-Hennkens HM, Junnotula S, Ma L, Gallazzi F, Lewis MR, Jurisson SS.

J Med Chem. 2008 Mar 13;51(5):1223-30. doi: 10.1021/jm701056x. Epub 2008 Feb 13.

PMID:
18269231
14.

Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.

Achilefu S, Srinivasan A, Schmidt MA, Jimenez HN, Bugaj JE, Erion JL.

J Med Chem. 2003 Jul 17;46(15):3403-11.

PMID:
12852770
15.

188Re- and 99mTc-MAG3 as prosthetic groups for labeling amines and peptides: approaches with pre- and postconjugate labeling.

Guhlke S, Schaffland A, Zamora PO, Sartor J, Diekmann D, Bender H, Knapp FF, Biersack HJ.

Nucl Med Biol. 1998 Oct;25(7):621-31.

PMID:
9804043
16.

Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re.

van Schaijk FG, Oosterwijk E, Soede AC, Oyen WJ, McBride WJ, Griffiths GL, Goldenberg DM, Corstens FH, Boerman OC.

Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3880S-5S.

18.

Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin.

Moustapha ME, Ehrhardt GJ, Smith CJ, Szajek LP, Eckelman WC, Jurisson SS.

Nucl Med Biol. 2006 Jan;33(1):81-9.

PMID:
16459262
19.

Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy.

Polyakov V, Sharma V, Dahlheimer JL, Pica CM, Luker GD, Piwnica-Worms D.

Bioconjug Chem. 2000 Nov-Dec;11(6):762-71.

PMID:
11087323
20.

Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents.

Achilefu S, Jimenez HN, Dorshow RB, Bugaj JE, Webb EG, Wilhelm RR, Rajagopalan R, Johler J, Erion JL.

J Med Chem. 2002 May 9;45(10):2003-15.

PMID:
11985468

Supplemental Content

Support Center